Search Article 
 
Advanced search 
Official publication of the American Biodontics Society and the Center for Research and Education in Technology
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL HYPOTHESIS
Year : 2021  |  Volume : 12  |  Issue : 2  |  Page : 96-98

Topical Oral Melatonin Application Could Potentially Reduce the Risk of Orthodontic Appliance-Induced Periodontal Deterioration


1 Department of Dentistry, Bharathirajaa Hospital and Research Institute, T Nagar, Chennai, India
2 Department of Periodontics, Tagore Dental College and Hospital, Chennai, India
3 Cranio Facial Clinic (P) Ltd., Chennai, India
4 Department of Pedodontics and Preventive Dentistry, Tagore Dental College and Hospital, Chennai, India
5 Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India
6 Department of Conservative Dentistry, Sathyabama Dental College and Hospital, Chennai, India

Correspondence Address:
Thodur Madapusi Balaji
Department of Dentistry, Bharathirajaa Hospital and Research Institute, T Nagar, Chennai
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/denthyp.denthyp_125_20

Rights and Permissions

Introduction: Although patients derive numerous aesthetic and functional benefits by wearing orthodontic appliances, they also undergo some adverse changes in the oral cavity such as chronic generalized marginal gingivitis and localized gingival enlargements that can be concerning. Salivary changes following placement of fixed orthodontic appliances have been documented by numerous research papers. The Hypothesis: Melatonin in the form of an orabase gel with 1% to 2% concentration applied daily topically on the gingival tissues throughout the orthodontic treatment phase could boost the salivary antioxidant levels, neutralize the nickel and chromium toxicity, potentially attenuating inflammation, and fibrotic enlargements of the periodontal tissue. Evaluation of the Hypothesis: Testing the abovementioned hypothesis will involve a randomized double-blinded clinical trial with a placebo and test orabase gel with 1% to 2% melatonin as an active drug agent. Testing and validating the proposed hypothesis will throw open a new vista in using melatonin as a topical adjuvant in orthodontic appliance wearers.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed552    
    Printed8    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal